C
Candel Therapeutics, Inc.
CADL · NASDAQ · Healthcare · 859M
Closing price
$9.94
+2.90% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
10.1×
Enterprise value / EBITDAEV/EBITDA
-11.6×
Free cash flow yieldFCF yield
-7.4%
Return on equityROE
-73.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
3.3×
Interest coverage
-22.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.